Sara J Redler, PHARMD | |
317 Dakota Dunes Blvd Ste A, Dakota Dunes, SD 57049-5341 | |
(171) 256-0221 | |
Not Available |
Full Name | Sara J Redler |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 317 Dakota Dunes Blvd Ste A, Dakota Dunes, South Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306420203 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | R5651 (South Dakota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Sara J Redler, PHARMD 317 Dakota Dunes Blvd Ste A, Dakota Dunes, SD 57049-5341 Ph: (171) 256-0221 | Sara J Redler, PHARMD 317 Dakota Dunes Blvd Ste A, Dakota Dunes, SD 57049-5341 Ph: (171) 256-0221 |
News Archive
Ryan & Maniskas, LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the Board of Directors of BioSphere Medical, Inc. in connection with their actions in causing BioSphere Medical to enter into a merger agreement with Merit Medical System, Inc. and Merit BioAcquisition Co., a wholly-owned subsidiary of Merit Medical pursuant to which BioSphere Medical will merge with and into Merit BioAcquisition Co.
We take it for granted, but the fact that our muscles grow when we work them makes them rather unique. Now, researchers have identified a key ingredient needed for that bulking up to take place. A factor produced in working muscle fibers apparently tells surrounding muscle stem cell "higher ups" that it's time to multiply and join in, according to a study in the January Cell Metabolism, a Cell Press journal.
Bacteria have many methods of adapting to resist antibiotics, but a new class of spiral polypeptides developed at the University of Illinois targets one thing no bacterium can live without: an outer membrane.
Novasep, a provider of purification-based manufacturing solutions for lifescience molecules, has announced that Cerenis Therapeutics has been invited by BioProcess International to present its major project CER – 001 ApoA1 - HDL mimetic drug candidate, and describe how Novasep played a critical role in the project by successfully achieving the transfer and scale up of Apo-A1 production.
› Verified 8 days ago
Dr. Teresa J Broers Orlando, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 Tower Rd Ste 130, Dakota Dunes, SD 57049 Phone: 605-242-5050 Fax: 605-242-5052 |